6月5日,康诺亚-B(02162)发布公告,公司全资附属公司一桥香港已完成对OuroMedicines的股权出售。 根据公告,公司已于2026年6月5日收到2.57亿美元的首付款。此次交易的首付款为16.75亿美元,外加最高5亿美元的潜在里程碑付款。 作为OuroMedicines的股东,公司将获得约2.57亿美元的首付款及最高约7000万美元的里程碑付款。此外,公司与...
Source Link6月5日,康诺亚-B(02162)发布公告,公司全资附属公司一桥香港已完成对OuroMedicines的股权出售。 根据公告,公司已于2026年6月5日收到2.57亿美元的首付款。此次交易的首付款为16.75亿美元,外加最高5亿美元的潜在里程碑付款。 作为OuroMedicines的股东,公司将获得约2.57亿美元的首付款及最高约7000万美元的里程碑付款。此外,公司与...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.